Stockreport

Down 13.69%: Is Sage Therapeutics Stock a Bad-News Buy? [The Motley Fool]

Sage Therapeutics, Inc.  (SAGE) 
Last sage therapeutics, inc. earnings: 2/27 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.sagerx.com/investor-relations
PDF Sage's lead drug candidate whiffs in a late-stage study. George Budwell ( TMFGBudwell ) [Read more]